Leavell Investment Management Inc. Purchases 5,297 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Leavell Investment Management Inc. grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 19.4% during the 4th quarter, Holdings Channel reports. The firm owned 32,653 shares of the company’s stock after purchasing an additional 5,297 shares during the period. Leavell Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $2,553,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Cherry Creek Investment Advisors Inc. lifted its holdings in GE HealthCare Technologies by 0.3% in the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock valued at $2,920,000 after buying an additional 114 shares during the period. Independence Bank of Kentucky raised its position in shares of GE HealthCare Technologies by 6.0% during the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock valued at $158,000 after acquiring an additional 114 shares during the last quarter. Tandem Capital Management Corp ADV lifted its stake in shares of GE HealthCare Technologies by 0.4% in the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock valued at $2,205,000 after purchasing an additional 118 shares during the period. Custom Index Systems LLC boosted its position in shares of GE HealthCare Technologies by 4.4% in the 4th quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock worth $222,000 after purchasing an additional 120 shares during the last quarter. Finally, Greenleaf Trust grew its stake in shares of GE HealthCare Technologies by 1.7% during the third quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock worth $715,000 after purchasing an additional 124 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 1.3 %

Shares of GEHC stock opened at $85.90 on Thursday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a fifty day moving average of $83.58 and a 200-day moving average of $85.39. The company has a market capitalization of $39.25 billion, a price-to-earnings ratio of 23.60, a P/E/G ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a $0.035 dividend. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on GEHC. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $96.77.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.